Neurological & Psychological Disorders
News on research and diagnostic developments in neuroscience.
Durin Technologies Closes $3.5M Funding Round
The company said it will use the funds to support commercialization of diagnostic tests for Alzheimer's and Parkinson's disease.
Octave Bioscience Wins $10M Grant From Michael J. Fox Foundation
The firm will use the funds to develop a protein panel that can help assess disease activity and progression in individuals with Parkinson's.
Roughly a year after its launch, the company's Multiple Sclerosis Disease Activity (MSDA) test is being used by several dozen clinics around the country.
Quanterix Plans to Wrap up Restructuring by End of Year; Q3 Revenues Grow 18 Percent
The company posted Q3 2023 revenues of $31.3 million, up from $26.6 million in Q3 2022 and beating the consensus Wall Street estimate of $27.6 million.
Research teams report progress in identifying the biomarkers of psychiatric disorders, and one team aims to deliver tests for use with psychiatric evaluations.